Literature DB >> 18534576

The role of the tetraspanin CD151 in primary keratinocyte and fibroblast functions: implications for wound healing.

Sean M Geary1, Allison J Cowin, Ben Copeland, Rosa M Baleato, Kaoru Miyazaki, Leonie K Ashman.   

Abstract

Previous studies showed that CD151-null mice have a skin wound healing deficit. To gain an understanding of the role of CD151 in re-epithelialisation and dermal contraction, keratinocyte and fibroblast functions were assayed. Primary CD151-null keratinocytes displayed defective migration on Matrigel (a basement membrane equivalent) and laminin-332, the primary adhesion component of basement membranes, but not on collagen-I. Adhesion, spreading and proliferation were also deficient on laminin-332, but not collagen-I. The data suggest that loss of CD151 impairs the function of its primary interaction partners, integrin alpha3beta1- and/or alpha6beta4 which bind to laminin-332. Skin fibroblasts also produce CD151 mRNA. CD151-null fibroblasts migrated significantly faster on collagen I than wild type fibroblasts, confirming that they possess functional collagen receptors. However, no significant decrease in the ability of CD151-null fibroblasts to cause contraction in floating collagen gel assays in response to transforming growth factor beta-1 (TGF-beta1) or platelet derived growth factor (PDGF-BB) was observed, nor was there an effect on fibroblast adhesion or proliferation on collagen-I. The data implicate CD151 as a facilitator of laminin-332-mediated keratinocyte functions that impact on the re-epithelialisation process intrinsic to wound healing and further suggest a potential novel role for CD151 in fibroblast migration.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18534576     DOI: 10.1016/j.yexcr.2008.04.011

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  11 in total

1.  Structure-function analysis of tetraspanin CD151 reveals distinct requirements for tumor cell behaviors mediated by α3β1 versus α6β4 integrin.

Authors:  Shannin Zevian; Nicole E Winterwood; Christopher S Stipp
Journal:  J Biol Chem       Date:  2010-12-30       Impact factor: 5.157

2.  Tetraspanin CD151 regulates growth of mammary epithelial cells in three-dimensional extracellular matrix: implication for mammary ductal carcinoma in situ.

Authors:  Vera Novitskaya; Hanna Romanska; Marwa Dawoud; J Louise Jones; Fedor Berditchevski
Journal:  Cancer Res       Date:  2010-05-25       Impact factor: 12.701

Review 3.  Tetraspanins in cell migration.

Authors:  Xupin Jiang; Jiaping Zhang; Yuesheng Huang
Journal:  Cell Adh Migr       Date:  2015-06-19       Impact factor: 3.405

4.  Tetraspanin, CD151, is required for maintenance of trigeminal placode identity.

Authors:  Kathryn L McCabe; Marianne Bronner
Journal:  J Neurochem       Date:  2011-02-24       Impact factor: 5.372

5.  CD151: Basis Sequence: Mouse.

Authors:  Trenis D Palmer; Andries Zijlstra
Journal:  AFCS Nat Mol Pages       Date:  2011

6.  High Yield Expression of Recombinant CD151 in E. coli and a Structural Insight into Cholesterol Binding Domain.

Authors:  Gayathri Purushothaman; Vijay Thiruvenkatam
Journal:  Mol Biotechnol       Date:  2019-12       Impact factor: 2.695

7.  Reduced susceptibility to two-stage skin carcinogenesis in mice with epidermis-specific deletion of CD151.

Authors:  Norman Sachs; Pablo Secades; Laura van Hulst; Ji-Ying Song; Arnoud Sonnenberg
Journal:  J Invest Dermatol       Date:  2013-06-21       Impact factor: 8.551

8.  Healing of excisional wound in alloxan induced diabetic sheep: A planimetric and histopathologic study.

Authors:  Siamak Kazemi-Darabadi; Farshid Sarrafzadeh-Rezaei; Amir-Abbas Farshid; Reza Baradar-Jalili
Journal:  Vet Res Forum       Date:  2013       Impact factor: 1.054

Review 9.  CD151-A Striking Marker for Cancer Therapy.

Authors:  Seema Kumari; Gayatri Devi; Anil Badana; Venkata Ramesh Dasari; Rama Rao Malla
Journal:  Biomark Cancer       Date:  2015-03-22

Review 10.  Laminin-binding integrins and their tetraspanin partners as potential antimetastatic targets.

Authors:  Christopher S Stipp
Journal:  Expert Rev Mol Med       Date:  2010-01-18       Impact factor: 5.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.